Hide This

FREEHER HealthToolkit

HER Health Toolkit

Sign up for EmpowHER updates and you'll receive our
FREE HER Health Toolkit

Cancer

Get Email Updates

Cancer Guide

Maryann Gromisch RN Guide

Have a question? We're here to help. Ask the Community.

ASK

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!

Drug Company Reverses Drug Decision for 7-year-old Cancer Patient

By Lynette Summerill HERWriter
 
Rate This
Drug Company Reverses Drug Decision for 7-year-old Cancer Patient 0 5
Drug company reverses decision for 7-year-old who has cancer
PS Productions/PhotoSpin

Josh Hardy is a critically ill 7-year-old boy from Fredericksburg, Virginia with a rare form of metastatic kidney cancer. He will get the experimental antiviral drug, brincidofovir, after his family pleaded with the pharmaceutical company.

On March 11, 2014 the Chimerix pharmaceutical company announced that Josh would receive the medicine his doctors hope will save his life as he becomes the first patient in a new clinical trial that started March 12, 2014.

The company had previously denied desperate appeals from the boy’s family to give him the experimental drug. At the time they cited that focusing time on helping Josh and others like him would slow down efforts to get the drug to market to treat so many more with similar conditions.

After the decision reversal, a spokesman for the drug company said he hopes that the government-approved trial will help Josh and many other patients like him.

Josh's story drew national attention as his parents and thousands of supporters pushed the company to change its mind in online and media campaigns.

After learning her son would receive the drug, mother Aimee Hardy praised the company’s decision in an emotional Facebook post.

"Glory to GOD!" she wrote. "They are releasing the drug for Josh!!!!!!!!!"

The little boy’s journey started at 9 months when he was diagnosed with the rare cancer. Over the years, cancer spread to his thymus, lung, and bone marrow, and each time Josh beat it.

But the bone marrow transplant compromised Josh’s immune system and in February, doctors diagnosed him with an adenovirus that has left him in critical condition in an Intensive Care Unit.

Josh Hardy is in heart and kidney failure and vomits blood several times a hour, CNN reported.

His doctors at St. Jude Children's Research Hospital in Memphis had also been pushing the company to provide the drug under a U.S. Food and Drug Administration (FDA) policy known as "compassionate use".

The policy allows someone with a serious or life-threatening disease to ask a drug company for an experimental drug.

Add a Comment1 Comments

EmpowHER Guest
Anonymous

It has become easier for me to take information from the contents. Please Visit

March 20, 2014 - 12:37am
Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Improved

1679 Health

Changed

630 Lives

Saved

479 Lives
3 lives impacted in the last 24 hrs Learn More

Take Our Featured Health Poll

Have you ever participated in a clinical trial?:
View Results